title: [Demyelinating encephalomyelitis associated with treatment with adalimumab].
authors.forename: M
authors.initials: M
authors.lastname: Sillero Sánchez
authors.forename: G
authors.initials: G
authors.lastname: García Domínguez
authors.forename: J J
authors.initials: JJ
authors.lastname: Asencio Marchante
mesh_terms: D000068879:Adalimumab; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D003711:Demyelinating Diseases / Q000139:chemically induced / Q000473:pathology; D004679:Encephalomyelitis / Q000139:chemically induced / Q000473:pathology; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008875:Middle Aged
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab